SEC Form 3 · accession 0001209191-18-058051

ACADIA PHARMACEUTICALS INC · ACAD

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — Controller & PAO

Period of report

Nov 2, 2018

Accepted (ET)

Nov 9, 2018 · 8:06 pm EST

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001070494

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common Stock	holding	—	—		—	3,212	D

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Employee Stock Option (Right to Buy)^F1	$20.65	holding	—	—	—	—	May 29, 2024	Common Stock	7,500	—	D
Employee Stock Option (Right to Buy)^F2	$32.28	holding	—	—	—	—	Jan 25, 2025	Common Stock	3,900	—	D
Employee Stock Option (Right to Buy)^F3	$29.24	holding	—	—	—	—	Jan 5, 2026	Common Stock	6,615	—	D
Employee Stock Option (Right to Buy)^F4	$36.54	holding	—	—	—	—	Mar 7, 2027	Common Stock	7,350	—	D
Employee Stock Option (Right to Buy)^F5	$35.80	holding	—	—	—	—	Sep 6, 2027	Common Stock	9,187	—	D
Employee Stock Option (Right to Buy)^F6	$16.50	holding	—	—	—	—	Apr 6, 2028	Common Stock	5,570	—	D
Employee Stock Option (Right to Buy)^F7	$21.28	holding	—	—	—	—	Oct 14, 2028	Common Stock	3,342	—	D
Restricted Stock Units^F9,F8	—	holding	—	—	—	—	—	Common Stock	1,671	—	D

F1This option is fully vested and exercisable.
F225% of the shares subject to the Stock Option vested and became exercisable on January 1, 2016, and the remaining shares vest and become exercisable in 36 equal monthly installments thereafter.
F325% of the shares subject to the Stock Option vested and became exercisable on January 1, 2017, and the remaining shares vest and become exercisable in 36 equal monthly installments thereafter.
F425% of the shares subject to the Stock Option vested and became exercisable on March 8, 2018, and the remaining shares vest and become exercisable in 36 equal monthly installments thereafter.
F525% of the shares subject to the Stock Option vested and became exercisable on September 7, 2018, and the remaining shares vest and become exercisable in 36 equal monthly installments thereafter.
F625% of the shares subject to the Stock Option vest and become exercisable on April 7, 2019, and the remaining shares vest and become exercisable in 36 equal monthly installments thereafter.
F725% of the shares subject to the Stock Option vest and become exercisable on October 15, 2019, and the remaining shares vest and become exercisable in 36 equal monthly installments thereafter.
F8The restricted stock units vest in four equal annual installments beginning October 15, 2019.
F9Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.